Surprisingly, it was demonstrated that MMP-9 does not cleave human IgG or IgM (74), which would constitute a benefit for the use of neutralizing antibodies against MMP-9 in conditions with considerable MMP-9 levels, such as IBD. Here, MMP9 is linked to inflammatory bowel disease.